If a company can obtain a price that covers the marginal cost of producing and marketing a drug while satisfying regulatory policies, selling the drug in a given country makes sense.
In the most recent installment of On the Issues, AEI scholars examine the ways that the U.S. auto industry can survive the current economic crisis without a government bailout.
Would you like us to mail you printed copies of publications in addition to your personalized My AEI e-mail updates? Consider enrolling in the AEI Associates Program with a tax-deductible contribution. As an associate, you will receive print versions of many AEI publications, including the AEI Newsletter, On the Issues articles, and The American.
